
To the Editor:— Dr. Krugman and his associates deserve congratulations for their study of infectious hepatitis reported inThe Journal, Oct. 15, 1960. However, their statement concerning the optional dose of gamma globulin for the prevention of infectious hepatitis merits discussion. The authors think that 0.01 ml. is perhaps "adequate for the prevention of the mild childhood disease but inadequate for the adult type." On the basis of their experience, and because they could find no published evidence, they believe this dose is not enough for adults. As to their experience with adults in Willowbrook, it was very small, and one may ask if the attendants inoculated and uninoculated with 0.01 ml. were equally exposed to hepatitis. In 1953-1954 the New York State Department of Health studied the families of 2,000 reported patients with infectious hepatitis. Some of the families were inoculated with gamma globulin; others, for various reasons, were
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
